Farmako ApS — Credit Rating and Financial Key Figures

CVR number: 40143548
Ny Carlsberg Vej 80, 1799 København V
anna.kouparanis@farmako.de

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
Gross profit-28.97-26.93-13.13-13.50-16.88
EBIT-28.97-26.93-13.13-13.50-16.88
Other financial expenses-0.00
Pre-tax profit-28.97-26.93-13.13-13.50-16.88
Net earnings-28.97-26.93-13.13-13.50-16.88

Assets (kDKK)

2019
2020
2021
2022
2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables33.536.856.856.856.85
Short term receivables total33.536.856.856.856.85
Balance sheet total (assets)33.536.856.856.856.85

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital50.0050.0050.0050.0050.00
Retained earnings-28.97-55.90-69.03-82.53
Profit of the financial year-28.97-26.93-13.13-13.50-16.88
Shareholders equity total21.03-5.90-19.03-32.53-49.40
Non-current liabilities total
Current owed to group member12.7525.8840.88
Other non-interest bearing current liabilities12.5012.7513.1313.5015.38
Current liabilities total12.5012.7525.8839.3856.25
Balance sheet total (liabilities)33.536.856.856.856.85
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.